Cargando…

What should be done in patients diagnosed with xanthogranulomatous cholecystitis? Case-control study

OBJECTIVE: In this study, we aimed to compare development of complications, malignancy and confusion rates in the preliminary diagnosis in patients with xanthogranulomatous cholecystitis identified. METHODS: In this study, 2803 patients undergone cholecystectomy between January 2010 and December 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Canbak, Tolga, Acar, Aylin, Tolan, Huseyin Kerem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603842/
https://www.ncbi.nlm.nih.gov/pubmed/33163882
http://dx.doi.org/10.14744/nci.2020.35848
_version_ 1783604011474092032
author Canbak, Tolga
Acar, Aylin
Tolan, Huseyin Kerem
author_facet Canbak, Tolga
Acar, Aylin
Tolan, Huseyin Kerem
author_sort Canbak, Tolga
collection PubMed
description OBJECTIVE: In this study, we aimed to compare development of complications, malignancy and confusion rates in the preliminary diagnosis in patients with xanthogranulomatous cholecystitis identified. METHODS: In this study, 2803 patients undergone cholecystectomy between January 2010 and December 2016 were retrospectively evaluated. Patients with xanthogranulomatous cholecystitis identified in the histopathological examination were classified as Group 1 and patients with cholelithiasis, cholecystitis, and malignancy detected were classified as Group 2. RESULTS: Forty-five patients with xanthogranulomatous cholecystitis were classified as group 1 and 2758 patients as group 2. of group 1, 18 were male and group 2 consisted of 2758 patients with 707 (26%) being male (p=0.04). In the ultrasonographic examination, the wall thickness was increased in 40 patients in Group 1 and 662 patients in Group 2 (p<0.0001). The operation was converted to the open type in 24 patients in Group 1 and 61 patients in Group 2 (p<0.0001). Five patients in Group 1 and 32 patients in Group 2 developed complications in the postoperative period (p<0.0001). CONCLUSION: Xanthogranulomatous cholecystitis should be considered for the differential diagnosis and the operation should be performed, especially by carefully exposing the anatomy in these patients.
format Online
Article
Text
id pubmed-7603842
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-76038422020-11-06 What should be done in patients diagnosed with xanthogranulomatous cholecystitis? Case-control study Canbak, Tolga Acar, Aylin Tolan, Huseyin Kerem North Clin Istanb Original Article OBJECTIVE: In this study, we aimed to compare development of complications, malignancy and confusion rates in the preliminary diagnosis in patients with xanthogranulomatous cholecystitis identified. METHODS: In this study, 2803 patients undergone cholecystectomy between January 2010 and December 2016 were retrospectively evaluated. Patients with xanthogranulomatous cholecystitis identified in the histopathological examination were classified as Group 1 and patients with cholelithiasis, cholecystitis, and malignancy detected were classified as Group 2. RESULTS: Forty-five patients with xanthogranulomatous cholecystitis were classified as group 1 and 2758 patients as group 2. of group 1, 18 were male and group 2 consisted of 2758 patients with 707 (26%) being male (p=0.04). In the ultrasonographic examination, the wall thickness was increased in 40 patients in Group 1 and 662 patients in Group 2 (p<0.0001). The operation was converted to the open type in 24 patients in Group 1 and 61 patients in Group 2 (p<0.0001). Five patients in Group 1 and 32 patients in Group 2 developed complications in the postoperative period (p<0.0001). CONCLUSION: Xanthogranulomatous cholecystitis should be considered for the differential diagnosis and the operation should be performed, especially by carefully exposing the anatomy in these patients. Kare Publishing 2020-09-01 /pmc/articles/PMC7603842/ /pubmed/33163882 http://dx.doi.org/10.14744/nci.2020.35848 Text en Copyright: © 2020 by Istanbul Northern Anatolian Association of Public Hospitals http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Original Article
Canbak, Tolga
Acar, Aylin
Tolan, Huseyin Kerem
What should be done in patients diagnosed with xanthogranulomatous cholecystitis? Case-control study
title What should be done in patients diagnosed with xanthogranulomatous cholecystitis? Case-control study
title_full What should be done in patients diagnosed with xanthogranulomatous cholecystitis? Case-control study
title_fullStr What should be done in patients diagnosed with xanthogranulomatous cholecystitis? Case-control study
title_full_unstemmed What should be done in patients diagnosed with xanthogranulomatous cholecystitis? Case-control study
title_short What should be done in patients diagnosed with xanthogranulomatous cholecystitis? Case-control study
title_sort what should be done in patients diagnosed with xanthogranulomatous cholecystitis? case-control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603842/
https://www.ncbi.nlm.nih.gov/pubmed/33163882
http://dx.doi.org/10.14744/nci.2020.35848
work_keys_str_mv AT canbaktolga whatshouldbedoneinpatientsdiagnosedwithxanthogranulomatouscholecystitiscasecontrolstudy
AT acaraylin whatshouldbedoneinpatientsdiagnosedwithxanthogranulomatouscholecystitiscasecontrolstudy
AT tolanhuseyinkerem whatshouldbedoneinpatientsdiagnosedwithxanthogranulomatouscholecystitiscasecontrolstudy